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A comparison of two commercially available ELISA methods
for the quantification of human plasma heat shock protein 70
during rest and exercise stress
Background. This study compared resting and exercise heat/hypoxic-stress induced
levels of plasma eHSP70 in humans using two commercially available ELISA kits.
Methods. EDTA plasma samples were collected from 21 males during two separate
investigations. Participants in Part A completed a 60 min treadmill run in the heat (HOT70;
33.0 ± 0.1 °C, 28.7 ± 0.8%, n = 6) at 70% V̇O2max. Participants in Part B completed 60
minutes of cycling exercise at 50% V̇O2max in either hot (HOT50; 40.5°C, 25.4 RH%, n = 7)
or hypoxic (HYP50; FIO2 = 0.14, 21°C, 35% RH, n = 8) conditions. Samples were collected
prior to and immediately upon termination of exercise and analysed for eHSP70 using EKS-
715 high sensitivity HSP70 ELISA, and new ENZ-KIT-101 AMP’D™ HSP70 high sensitivity
ELISA. Results. ENZ-KIT was superior in detecting resting eHSP70 (1.54 ± 3.27 ng.mL-1;
range 0.08 to 14.01 ng.mL-1), with concentrations obtained from 100% of samples
compared to 19% with EKS-715 assay. The ENZ-KIT requires optimisation prior to running
samples in order to ensure participants fall within the standard curve, a step not required
with EKS-715. Using ENZ-KIT, a 1:4 dilution allowed for quantification of resting HSP70 in
26/32 samples, with a 1:8 (n = 3) and 1:16 (n = 3) dilution required to determine the
remaining samples. After exercise eHSP70 was detected in 6/21 and 21/21 samples using
EKS-715 and ENZ-KIT respectively. eHSP70 was increased from rest after HOT70 (p <
0.05), but not HOT50 (p > 0.05) or HYP50 (p > 0.05) when analysed using ENZ-KIT.
Conclusion. It is recommended that future studies requiring the precise determination of
resting plasma eHSP70 use the ENZ-KIT (i.e., HSP70 Amp'd®ELISA) instead of the EKS-715
assay, despite additional assay development time and cost required.
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Abstract 35 
Background. This study compared resting and exercise heat/hypoxic-stress induced 36 
levels of plasma eHSP70 in humans using two commercially available ELISA kits. 37 
Methods. EDTA plasma samples were collected from 21 males during two separate 38 
investigations. Participants in Part A completed a 60 min treadmill run in the heat 39 
(HOT70; 33.0 ± 0.1 °C, 28.7 ± 0.8%, n = 6) at 70% V̇O2max. Participants in Part B 40 
completed 60 minutes of cycling exercise at 50% V̇O2max in either hot (HOT50; 41 
40.5°C, 25.4 RH%, n = 7) or hypoxic (HYP50; FIO2 = 0.14, 21°C, 35% RH, n = 8) 42 
conditions. Samples were collected prior to and immediately upon termination of 43 
exercise and analysed for eHSP70 using EKS-715 high sensitivity HSP70 ELISA, and 44 
new ENZ-KIT-101 AMP’D™ HSP70 high sensitivity ELISA.   45 
Results. ENZ-KIT was superior in detecting resting eHSP70 (1.54 ± 3.27 ng.mL-1; 46 
range 0.08 to 14.01 ng.mL-1), with concentrations obtained from 100% of samples 47 
compared to 19% with EKS-715 assay. The ENZ-KIT requires optimisation prior to 48 
running samples in order to ensure participants fall within the standard curve, a step 49 
not required with EKS-715.  Using ENZ-KIT, a 1:4 dilution allowed for 50 
quantification of resting HSP70 in 26/32 samples, with a 1:8 (n = 3) and 1:16 (n = 3) 51 
dilution required to determine the remaining samples. After exercise eHSP70 was 52 
detected in 6/21 and 21/21 samples using EKS-715 and ENZ-KIT respectively. 53 
eHSP70 was increased from rest after HOT70 (p < 0.05), but not HOT50 (p > 0.05) or 54 
HYP50 (p > 0.05) when analysed using ENZ-KIT.  55 
Conclusion. It is recommended that future studies requiring the precise determination 56 
of resting plasma eHSP70 use the ENZ-KIT (i.e., HSP70 Amp'd® ELISA) instead of 57 
the EKS-715 assay, despite additional assay development time and cost required.  58 
 59 
Introduction 60 
Heat shock proteins (HSPs) are an evolutionarily conserved family of proteins, with 61 
individual members named according to their molecular weight. Intracellular HSPs 62 
are expressed both constitutively and accumulate after exposure to a wide array of 63 
physiological and psychological stressors (Mosely 1996; Kregal 2002; Horowitz 64 
2007). The 70 kilodalton (kDa) HSP (HSP70/HSPA1A, Kampinga et al. 2009) 65 
remains the most widely studied member of the HSP family due to its multiple 66 
functions related to de novo protein folding (Fink 1999), refolding (Hartl 1996), 67 
degradation (Garrido et al. 2001) and intracellular anti-inflammatory action observed 68 
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following induction (Ianaro et al. 2001) – all important factors in the maintenance of 69 
protein homeostasis. 70 
 71 
In addition to its intracellular HSP70 (iHSP70) function, HSP70 has been detected in 72 
the circulation (i.e., plasma; Pockley et al. 1998), where it is described as an 73 
extracellular HSP (eHSP, Fleshner et al. 2003). Extracellular HSP70 stimulates 74 
neutrophil microbiocidal activity (Ortega et al. 2006), chemotaxis (Ortega et al. 75 
2009), and induces cytokine production via a CD14 mediated pathway (Asea et al. 76 
2000), thereby promoting innate immune activation (Krause et al. 2015). Elevated 77 
resting concentrations of eHSP70 has been positively correlated with insulin 78 
resistance (Krause et al. 2014), and disease progression in auto-immune (Luo et al. 79 
2008) and inflammatory diseases (Schick et al. 2004; Najafizadeh et al. 2015). 80 
Therefore eHSP70 may be a useful biomarker when monitoring the progression of 81 
diseases in which low grade inflammation plays a role (Krause et al. 2012), such as 82 
sarcopenia (Ogawa et al. 2012), rheumatoid arthritis (Najafizadeh et al. 2015), 83 
diabetes (Krause et al. 2014), and obesity (Chung et al. 2008). The balance between 84 
the anti-inflammatory action of iHSP70, and pro-inflammatory action eHSP70, may 85 
determine the outcome (induction or attenuation of inflammation) during disease 86 
progression, in response to a treatment, or following an exercise bout (Krause et al. 87 
2015). Therefore understanding the eHSP70 response and its actions is of importance 88 
in clinical situations.  89 
 90 
In many studies the determination of basal eHSP70 has proven to be problematic 91 
(Ogawa et al. 2012; Lee et al. 2014; Najafizadech et al. 2015) with no consensus 92 
normative data for resting eHSP70 reported to date. Sample handling considerations 93 
(e.g., blood collection tubes temporarily stored on ice versus room temperature, using 94 
Heparin versus EDTA as an anticoagulant) have been suggested as explanations 95 
underlying the variability in eHSP70 values reported in the literature. For example, 96 
serum appears to yield lower basal values than those obtained by plasma (Whitham 97 
and Fortes 2006), which may be an artifact of eHSP70 binding to proteins involved in 98 
the clotting process, such as fibrin and fibrinogen (Whitham and Fortes 2006). 99 
Additionally, EDTA is recommended for use over heparin as higher resting 100 
concentrations are derived (Whitham and Fortes, 2006). Despite the recommendation 101 
to use EDTA plasma for eHSP70 determination (Whitham and Fortes 2006), multiple 102 
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studies have attempted to quantify eHSP70 in serum for a range of conditions, with 103 
varied results (Dulin et al. 2010; Najafizadeh et al. 2015).  104 
 105 
Another factor affecting the detection of eHSP70 in the circulation at rest could be 106 
attributed to the sensitivity and detection capabilities of the most widely cited enzyme 107 
linked immunosorbant assay (ELISA), ‘EKS-715 HSP70 high sensitivity ELISA’ 108 
(Enzo life sciences, Lausen, Switzerland). This assay, which has been cited by many 109 
papers investigating eHSP70 in humans, has a working range of 0.20 – 12.5 ng.mL-1, a 110 
sensitivity of 0.09 ng.mL-1, and is recommended by Cell Stress Society International 111 
(2011). In studies investigating eHSP70, resting values are highly variable, with many 112 
papers unable to detect basal eHSP70 in participants (Lee et al. 2014; Gibson et al. 113 
2014), or concentrations reported at the lower portion of a standard curve (< 0.20 114 
ng.mL-1, Ogawa et al. 2012; Rodrigues-Krause et al. 2012; Gibson et al. 2014; Lee et 115 
al. 2014; Lee et al. 2015). This issue appears not to be uniform in the literature 116 
however, as some studies report concentrations that are much higher (17.0 ± 2.6 117 
ng.mL-1; Ruell et al. 2006).  118 
 119 
A new ELISA has become available (ENZ-KIT-101-001 HSP70 Amp'd® ELISA), 120 
sensitive to 0.007 ng.mL-1 with a working range of 0.039-5.00 ng.mL-1. The increased 121 
sensitivity of this kit is mediated by an alkaline-phosphotase (AP) conjugate binding 122 
to a signal amplification substrate, which enhances colour production at lower analyte 123 
concentrations.  The increased sensitivity therefore affords the potential to determine 124 
normative resting eHSP70 values for a range of individuals with a variety of 125 
conditions and could allow for a more sensitive determination of stress-induced 126 
changes in eHSP70.  127 
 128 
Exercise stress can be used as a tool to study the eHSP70 response. Following 129 
exercise, both with and without a thermal component, eHSP70 is elevated in the 130 
circulation in a duration and intensity dependent manner (Whitham et al. 2007; 131 
Selkirk et al. 2009; Periard et al. 2013; Gibson et al. 2014; Lee et al. 2015). The 132 
magnitude of the post-exercise eHSP70 response has been related to a minimum 133 
endogenous requirement, which suggests that thresholds of core temperature, rate of 134 
core temperature change, and parasympathetic/sympathetic drive all play as of yet 135 
undetermined roles in the magnitude of this response (Gibson et al. 2014). A better 136 
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understanding of the criteria required to increase or decrease circulating eHSP70 may 137 
provide researchers with a useful biomarker for assessing therapeutic approaches to 138 
inflammation-related diseases, as well as improve understanding regarding eHSP70 139 
function following acute exercise, and repeated periods of exercise, adaptation, and 140 
acclimation to extreme environments.  141 
 142 
The aim of this investigation was to compare resting and exercise induced levels of 143 
EDTA plasma eHSP70 in Humans using the EKS-715 high sensitivity HSP70 ELISA 144 
and ENZ-KIT-101 Amp’d® HSP70 High Sensitivity  ELISA methods. It was 145 
hypothesised that the use of the AP conjugate and signal amplification step would 146 
allow a more sensitive determination of basal eHSP70 within different cohorts of 147 
participants at rest while also showing greater sensitivity to different levels of “stress” 148 
induced by exercise undertaken in different environmental conditions.   149 
 150 
Materials and Methods 151 
Participants 152 
Twenty-one recreationally active healthy males provided signed informed consent 153 
prior to participation in this study, which was granted approval by the NHS South-154 
West Research Ethics Committee (Reference ID. 14/SW/0098, Part A) and Coventry 155 
University local ethics committee (Part B). All procedures were conducted in 156 
accordance with the principles outlined in the Declaration of Helsinki. Data reported 157 
in this investigation were collected from two larger experimental trials (Lee, 2014). 158 
The collected data represents a convenience sample of similarly characterised 159 
individuals providing EDTA treated plasma before and after a 60-minute bout of 160 
exercise under conditions of environmental stress.   161 
All participants described themselves to be physically active, non-smokers with no 162 
prior history of cardiorespiratory illness. Participants were requested to abstain from 163 
caffeine (Lu et al. 2008) and alcohol consumption, as well as prolonged thermal 164 
exposures (baths, saunas, steam rooms, and tanning devices) for 72 hours prior to 165 
each laboratory visit, which were scheduled at similar times (08:30-09:30) between 166 
participants and trials. Participants adhered to an overnight fast prior to each trial and 167 
did not eat until after the final blood withdrawal.  168 
 169 
Preliminary measurements  170 
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Participants in each part of the study were assessed for height, body mass and 171 
percentage body fat in accordance with the International Society for the Advancement 172 
of Kinathroprometry (ISAK) guidelines (Marfell-Jones et al. 2006).  173 
Participants in Part A (n = 6) of the investigation completed a continuous incremental 174 
running test to volitional exhaustion on a motorised treadmill (Woodway ELG70, 175 
Weiss, Germany). The test protocol was modified from that of Taylor et al. (1955) 176 
and was performed in thermoneutral conditions (19.7 ± 0.7 °C, 46.3 ± 4.0% RH). 177 
After a five-minute warm-up at 6 km·h-1, the test began at a speed of 10 km·h-1 on a 178 
1% inclination. Speed was then increased by 1 km·h-1 every three minutes until 179 
reaching 13 km·h-1, when inclination was increased by 2% every two minutes. 180 
Participants were instructed to run for as long as possible and signal when they felt 181 
they could only complete one more minute to allow for a final set of recordings. Peak 182 
oxygen consumption was determined for participants in Part B using an incremental 183 
exercise test to volitional exhaustion on calibrated SRM cycle ergometer (n = 15, 184 
Table 1) Schoberer Rad Meßtechnik, Welldorf, Germany). Resting blood lactate 185 
(Biosen C-Line analyser, EKF Diagnostics, Germany) was determined from a finger 186 
capillary whole blood sample following a 10-minute seated rest period. The test began 187 
at a workload of 70W for 4-minutes and was then increased by 35W every 4 minutes 188 
until a blood lactate value of > 4mmol.L-1 was reached. Thereafter, workload 189 
increased 35W every 2 minutes until volitional exhaustion. A cadence of 70 rev.min-1 190 
was maintained throughout. In both Part A and Part B, expired gases were collected 191 
using 200L Douglas bags (Cranlea & Co, Birmingham, UK) during the final minute 192 
of each stage. Heart rate (Polar FT1, Polar Electro OY, Kempele, Finland) and 193 
perceived exertion (Borg 1976) were measured at the end of each gas collection. 194 
Respiratory gas analysis was completed as previously described (Lee et al., 2014, Lee 195 
et al., 2015). Peak oxygen consumption was considered to be achieved if two of the 196 
following criteria were met: i) a respiratory exchange ratio of >1.1, ii) a heart rate 197 
greater than 95% of age predicted maximum (220−age) and iii) a final blood lactate 198 
value in excess of 8 mmol.mL-1.  199 
Experimental design 200 
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Samples for eHSP70 analysis were obtained from two separate experiments which 201 
both involved a resting measure of eHSP70 and a measurement collected immediately 202 
after a 60-minute bout of exercise.  203 
 204 
Part A 205 
Samples were obtained before and immediately after a 60 minute treadmill run at a 206 
speed equivalent of 70% V̇O2max  (HOT70) from 6 healthy males (mean ± SD; age 20 207 
± 2 years; height 1.79 ± 0.04 meters; body mass 71.8 ± 2.7 kg; % body fat, 11.8 ± 208 
3.3%; V̇O2max 57.9 ± 9.7 mL.kg-1.min-1). All trials were performed in an environmental 209 
chamber that was regulated at a dry bulb temperature of 33.0 ± 0.1°C and relative 210 
humidity (RH) of 28.7 ± 0.8%, with blood samples obtained at rest, upon termination 211 
of exercise. Participants (n = 6) returned to the lab on two more occasions each 212 
separated by 14 days, to provide 2 further resting samples, which formed part of a 213 
larger experiment. These resting samples were included in the present analysis of 214 
resting data.   215 
 216 
Part B  217 
Samples were obtained before and immediately after a 60 minutes of cycling at a 218 
power output equivalent of 50% V̇O2max  in either hot (HOT50; 40.5°C, 25.4 RH%) or 219 
hypoxic (HYP50; FIO2 of ~0.14, 21°C, 35% RH) conditions. The hypoxic 220 
environment was generated by an oxygen filtration device (Hypoxico HYP-123 221 
hypoxicator, New York, NY, USA) set to produce the desired FIO2. Participant 222 
characteristics for HOT50 (n = 7) were (mean ± SD):  age = 22 ± 5 years; height 1.76 223 
± 0.05 meters; body mass 70.9 ± 5.7 kg; % body fat 13.2 ± 4.0%, V̇O2max 54.9 ± 3.2 224 
mL.kg-1.min-1. Participant characteristics for HYP50 were: 23.4 ± 4 years; height 1.80 225 
± 0.08 meters; body mass 70.0 ± 9.1 kg; % body fat 12.6 ± 3.7 %; V̇O2max 52.2 ± 3.3 226 
mL.kg-1.min-1. 227 
Participant Preparation                                                                                                  228 
Participant preparation and physiological measurements were completed in the same 229 
manner and at the same time intervals for both Part A and B. Prior to each visit, 230 
participants adhered to an overnight fast (Febbraio et al. 2002) and consumed 500 ml 231 
of plain water one hour before in accordance with the American College of Sports 232 
Medicine position stance on hydration (Sawka et al. 2007). Upon arrival, participants 233 
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began by voiding their bladder to provide a sample for hydration assessment via urine 234 
specific gravity (USG; Atago Refractomer, Jencons Pls, Leighton Buzzard, UK) and 235 
urine osmolarity (Uosmo; Advanced 3300 Micro-Osmometer, Advanced Inc, 236 
Massachusetts, USA). Euhydration was assumed for urine specific gravity values of ≤ 237 
1.020 g·ml-1 and osmolarity values of ≤ 700 mOsm·kg-1 (Armstrong et al. 1994). This 238 
control was not violated by any participant during any trial. Following this, 239 
participants measured their own nude body mass (Seca 880, Seca, Hamburg, 240 
Germany), inserted a calibrated rectal thermistor probe (Grant Squirrel 2020, Grant 241 
Instruments, Shepreth, UK) to a depth of 10 cm, and fitted a telemetric heart rate 242 
monitor around their chest (Polar FT1, Polar Electro OY, Kempele, Finland). An 243 
indwelling cannula (BD Insyte-W, Becton Dickinson, Utah, USA) was then inserted 244 
2.5 cm into an antecubital vein of the participants left arm. After a 20 minute 245 
stabilisation period with the participant lying supine, a baseline 10 ml blood sample 246 
was then drawn, with patency of the cannula being maintained with saline (0.9% 247 
sodium chloride, Braun, Melsungen, Germany).  248 
Physiological Measurements                                                                                                   249 
Participants entered the regulated environmental chamber at 09:30. The exercise bout 250 
began with a standardised five minute warm-up, running on a motorised treadmill at a 251 
speed calculated to elicit a work rate of 50% V̇O2max on a fixed 1% inclination (Jones 252 
& Drust 1996) in Part A, or a 15 minute seated wash-in for the hypoxic gas in group 253 
B. Upon completion of the warm-up/wash-in period, participants in Part A began a 60 254 
minute run at a work rate of 70% V̇O2max and participants in Part B began 60 minutes 255 
of cycling exercise at 50% V̇O2max in the prescribed environmental conditions 256 
(HOT50 or HYP50).  257 
During exercise, heart rate (HR), rectal temperature (Trectal), ratings of perceived 258 
exertion (RPE) and thermal sensation (ISO, 1995, Part A, Part B) were all recorded at 259 
ten-minute intervals. The Physiological Strain Index (PSI) was subsequently 260 
calculated at each time point using heart rate and rectal temperature data as described 261 
by Moran et al. (1998). The Trectal area under curve was calculated using a 262 
modification of the trapezium rule (Hubbard et al. 1977) when Trectal exceeded 38.5°C 263 
(Cheuvront et al. 2008) and 39.0°C. A Trectal of 38.5°C was selected as a possible 264 
threshold for eHSP70 appearance (Gibson et al. 2014). In instances where participants 265 
PeerJ PrePrints | https://dx.doi.org/10.7287/peerj.preprints.1120v2 | CC-BY 4.0 Open Access | rec: 29 Aug 2015, publ: 29 Aug 2015
P
re
P
rin
ts
9 
 
did not complete the full 60 minute run/cycle, termination time was recorded and all 266 
aforementioned measures taken in the final minute before cessation.  267 
Determination of extracellular HSP70  268 
Circulating eHSP70 was assessed using two commercially available ELISAs, EKS-269 
715 high sensitivity HSP70 kit 270 
(http://static.enzolifesciences.com/fileadmin/files/manual/ADI-EKS-715_insert.pdf; 271 
hereafter referred to as EKS-715) and ENZ-KIT-101-001 Amp'd® HSP70 high 272 
sensitivity ELISA kit (http://static.enzolifesciences.com/fileadmin/files/manual/ENZ-273 
KIT-101_insert.pdf, hereafter referred to as ENZ-KIT) according to the 274 
manufacturer’s instructions (Enzo Lifesciences, Lausen, Switzerland).  275 
 276 
The ENZ-KIT is designed to replace traditional alkaline phosphatase substrates, such 277 
as pNPP (p-Nitrophenyl phosphate), with a combination substrate and amplifier 278 
system that results in greater sensitivity when compared to a classic substrate ELISA. 279 
In the ENZ-KIT, bound AP converts a substrate that is utilized in a second enzyme 280 
reaction system which is initiated by addition of the amplifier reagent.  Figure 1 281 
shows typical standard curves (n = 4) prepared on the same 96 well plate (HSP70 282 
Clear Mirotiter plate, catalogue number: 80-1581), using the same HSP70 high 283 
sensitivity standard (Cat no: 80-1776). HRP conjugate (Cat no: 80-1778) was added 284 
to HSP70 high sensitivity antibody (Cat no: 80-1777) and a TMB substrate (Cat no: 285 
80-0350) used to develop the EKS-715. For ENZ-KIT, an AP conjugate (Cat no: 80-286 
2600) was added to the HSP70 high sensitivity antibody (Cat no: 80-1777) and 287 
incubated with signal amplification substrate (Cat no: 80-2596) containing NADPH 288 
prior to a final amplification step (Cat no: 80-2598). The amplification step allows for 289 
greater (amplified) colour production at lower analyte concentrations resulting in an 290 
increased assay sensitivity (Figure 1).  291 
 292 
The EKS-715 kit has a sensitivity of 0.090 ng.mL-1 and a working range of 0.20 to 293 
12.5 ng.mL-1. The ENZ-KIT assay is sensitive to 0.007 ng.mL-1 with a working range 294 
of 0.039-5.00 ng.mL-1. Following an initial analysis of samples (one ENZ-KIT assay), 295 
it became apparent that the minimum recommended dilution of 1:4 was not sufficient 296 
in all cases, with some samples containing more HSP70 than the top standard. Thus a 297 
further analysis using 1:4, 1:8 and 1:16 dilution step with assay diluent (sodium 298 
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carbonate) was necessary to determine the optimal dilution for each sample, with 299 
results multiplied by the this dilution factor in order to give eHSP70 values in ng.mL-300 
1. Once the optimal sample dilution was determined for each participant on the ENZ-301 
KIT, pre and post exercise samples were analysed in duplicate. 302 
 303 
Statistical analysis 304 
A total of 32 resting blood samples from 21 individuals (11 repeat samples) were 305 
analysed for basal eHSP70. The between-assay co-efficient of variation was 306 
determined using standard concentration curves of 4 separate kits run using both 307 
EKS-715 and ENZ-KIT. The reliability of the ENZ-KIT assay was further assessed 308 
by comparing resting data obtained during a serial dilution test to the data obtained 309 
from a further assay on these samples measuring both pre and post exercise data. 310 
Where each ELISA method provided eHSP70 for paired samples, or samples assayed 311 
on separate occasions, Pearson correlations determined the relationship between each 312 
measurement. 313 
Mean and peak physiological, thermoregulatory and eHSP70 responses were analysed 314 
between groups using a one-way analysis of variance (ANOVA), and Tukey’s 315 
honestly different test to explore main effects. All data analysis was performed using 316 
PASW software version 20.0 for Mac (SPSS, Chicago, IL, USA).  317 
Stepwise multiple regression analysis was performed using the three dependent 318 
variables (time spent above Trectal 38.5°C, rate of change in Trectal, and AUC for Trectal 319 
38.5°C) that were significantly correlated to post exercise eHSP70 concentrations. 320 
The significance level was set at p < 0.05 for all analysis. Data are reported as means 321 
± SD unless otherwise stated and individual data shown where possible. 322 
 323 
Results 324 
 325 
pNPP Conjugate (EKS-715) compared with AP conjugate and amplifier 326 
substrate (ENZ-KIT) 327 
Figure 1 illustrates a typical standard curve when the pNPP conjugate and TMB 328 
substrate is used (closed circles) in comparison to the increased sensitivity obtained 329 
from the AP conjugate and amplifier solution (open circles). The intra-assay 330 
precision, obtained by determining the coefficient of variation between duplicate 331 
samples obtained from the standard curves on 4 separate plates, was 2.6% and 4.1% 332 
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for EKS-715 and ENZ-KIT respectively. These data are lower than the manufacturer 333 
reported intra-assay precision of between 3.9 and 11.4% for EKS-715, and 7 and 15% 334 
for the ENZ-KIT. Inter-assay precision was also determined from the standard curves 335 
of 4 separate assays performed on 4 separate occasions, and was 4.9% and 6.2% for 336 
EKS-715 and ENZ-KIT respectively. These values were also lower than manufacturer 337 
reported inter-assay variation (EKS-715 = 12.8 – 19.1%; ENZ-KIT = 7.7 – 9.7%). 338 
 339 
Extracellular HSP70 at rest 340 
The ENZ-KIT was able to detect basal eHSP70 in all 32 resting samples (Figure 2, 341 
1.54 ± 3.27 ng.mL-1). In contrast, the EKS-715 assay did not detect eHSP70 in 26 out 342 
of 32 resting samples analyzed (81%). When results were available from both kits (n 343 
= 6), there was a good correlation between values (r = 0.86, p = 0.0004, Figure 2), 344 
with values not significantly different between kits (t = 0.35, p = 0.72).  In 15 of the 345 
samples measured with ENZ-KIT (47%), eHSP70 was below the 0.20 ng.mL-1 limit 346 
of EKS-715 standard curve (0.15 ± 0.04 ng.mL-1; 95% CI = 0.13 to 0.17 ng.mL-1). 347 
 348 
A minimum dilution of 1:4 (sample to assay diluent) is recommended to remove 349 
matrix interference during the ENZ-KIT assay. In the present investigation we found 350 
the 1:4 dilution allowed for determination of basal HSP70 in 26/32 samples studied.  351 
For samples with resting concentrations of eHSP70 above the top standard 352 
concentration (5.00 ng.mL-1), a 1:8 dilution (n = 3) and 1:16 (n = 3) were required to 353 
locate data on the standard curve. No participants exhibited eHSP70 values below the 354 
detection limit of 0.039 ng.mL-1 using the ENZ-KIT  355 
 356 
A further determination of ENZ-KIT assay reliability was made by comparing resting 357 
eHSP70 data obtained from the serial dilution plate, to the resting data obtained 358 
during the test run on a separate plate (Part A: n = 6, Part B n = 15;  r = 0.998, p < 359 
0.001, Figure 2 Panel E and F), indicating good inter-assay reliability  (CV = 7.9%).  360 
 361 
Physiological and thermoregulatory responses to each stressor 362 
The duration of exercise undertaken at 70% V̇O2max (i.e., HOT70, 54.0 ± 9.4 363 
minutes) was shorter than the duration of exercise undertaken at 50% V̇O2max (i.e., 364 
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HOT50, HYP50, 60 ± 0.0 minutes; f (2, 18) = 4.25, p = 0.032). Physiological and 365 
thermoregulatory data are shown in Table 1.  366 
 367 
Although some thermoregulatory responses (peak, delta and rate of Trectal change) 368 
were greater in HOT50 compared to HYP50 (Table 1), no other differences in 369 
physiological response (e.g. mean and peak HR and PSI) were observed between 370 
these conditions. In contrast, greater mean and peak exercising HR and Trectal 371 
responses were observed in HOT70 compared to HOT50 and HYP50. Similarly, the 372 
delta change in Trectal, the rate of Trectal change, the duration of the exercise bout spent 373 
above both 38.5°C and 39.0°C and AUC for these temperatures were all greater in 374 
HOT70 compared to HOT50 and HYP50 (p < 0.05; Table 1). The data therefore 375 
indicate two different levels of physiological strain were achieved (HOT70 versus 376 
HOT50 and HYP50). 377 
 378 
The exercise-induced eHSP70 response  379 
In accordance with the resting data, EKS-715 only detected post exercise eHSP70 in 380 
the 6 samples that had detectable eHSP70 at rest, with 5 samples obtained in HYP50 381 
and 1 sample from the HOT50. Post exercise eHSP70 obtained from the EKS-715 kit 382 
(n = 6, 3.92 ± 4.34 ng.mL-1) had a good relationship to those obtained with the ENZ-383 
KIT (n = 6, 3.37 ± 5.38 ng.mL-1, r = 0.84).  384 
 385 
There was a significant group × time interaction (F (2, 17) = 4.235, p = 0.03) for 386 
eHSP70 when analyzed using ENZ-KIT. Resting HSP70 was higher in HOT70 than 387 
HOT50 or HYP50 group (p < 0.05; Figure 3).  388 
 389 
Exercise results in an increase in eHSP70 from 2.79 ± 2.59 ng.mL-1 (95% CI = 0.074 390 
to 5.51 ng.mL-1) at rest to 3.51 ± 2.90 ng.mL-1 (0.47 to 6.56 ng.mL-1) in the HOT70 391 
group (t = 3.82, p = 0.012). However, with the HOT50 trial, eHSP70 was unchanged 392 
from 0.22 ± 0.13 ng.mL-1 (95% CI = 0.084 to 0.362 ng.mL-1) at rest to 0.20 ± 0.16 393 
ng.mL-1 (95% CI = 0.034 to 0.370 ng.mL-1) following exercise (t = 0.886 p = 0.410). 394 
In addition, in the HYP50 trial, eHSP70 was unchanged from 2.82 ± 5.51 ng.mL-1 395 
(95% CI = 2.96 to 8.60 ng.mL-1) at rest to 2.85 ± 5.56 ng.mL-1 (95% CI = 2.98 to 8.69 396 
ng.mL-1) following exercise (t = 0.635, p = 0.545). Thus only HOT70 induced 397 
changes of eHSP70 above resting values (Figure 3).  398 
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 399 
Relationship between eHSP70 and thermo-physiological measures 400 
Time spent above 38.5°C (r = 0.54), rate of change in Trectal (r = 0.52), and AUC for 401 
Trectal 38.5°C (r = 0.47) were entered into a stepwise multiple regression analysis to 402 
assess the association of these variables in post exercise eHSP70 concentration. The 403 
only predictor variable was the duration of exercise above 38.5°C. The adjusted R2 for 404 
this model was 0.26 with a large standard error of 55.1.  405 
 406 
Discussion  407 
The aim of this study was to compare two commercially available high sensitivity 408 
ELISAs for the determination of eHSP70 in plasma. The results illustrate that the 409 
ENZ-KIT (Enzo Lifesciences, Lausen, Switzerland) is more sensitive than the EKS-410 
715 (Enzo Lifesciences, Lausen, Switzerland) when quantifying both resting and post 411 
exercise eHSP70 values in a sample of healthy, moderately trained males. The 412 
increased sensitivity and lower working range, facilitated by the use of amplifier 413 
reagents, significantly improves the ability of the ENZ-KIT assay to detect resting 414 
eHSP70 in plasma thereby supporting our hypothesis.  415 
 416 
In the present investigation only 6 of the 21 samples analysed using the EKS-715 kit 417 
allowed for the quantification of eHSP70 at rest and after exercise, whereas ENZ-KIT 418 
provided data for all resting and all post exercise samples (Figure 2, Panel B). The 419 
increased sensitivity of ENZ-KIT introduces the potential requirement for serial 420 
dilution of samples to ensure results are not above the standard curve, thereby 421 
reducing the reliance on extrapolation. In the current analysis, the manufacturers 422 
recommended minimum sample dilution of 1:4 was sufficient to detect eHSP70 in 423 
26/32 samples. Additional dilutions of 1:8 (n = 3) and 1:16 (n = 3) were necessary in 424 
the instances when data fell above the standard curve. It may be prudent for 425 
researchers using the ENZ-KIT to conduct a 1:4 and 1:8 serial dilution of all resting 426 
samples prior to full analysis to ensure that all samples can be analysed together, 427 
potentially saving both time and the additional cost of running more assays. The 428 
ENZ-KIT demonstrated excellent reproducibility between individual assay kits, with 429 
duplicate measurements of resting values highly correlated between assays (R2 = 0.99, 430 
Figure 2, Panel F).  431 
 432 
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Heat shock proteins play an important role in maintaining cellular protein 433 
homeostasis, with HSP dysfunction implicated in the pathology of Alzheimer’s 434 
disease, Parkinson’s disease, cardiovascular disease, and sarcopenia (Krause et al. 435 
2015). It is therefore surprising that there is currently no substantial normative data 436 
regarding resting eHSP70 for either healthy individuals or clinical cohorts. Indeed, a 437 
characteristic of eHSP70 research is the large variability both between studies (Ruell 438 
et al. 2006; Whitham and Fortes 2006; Gibson et al. 2014; Lee et al. 2015) and within 439 
studies, likely exacerbated by small samples sizes typically used in exercise studies 440 
(Gibson et al. 2014; Lee et al. 2015). Between-participant variation is evident in the 441 
present investigation, in which three groups of seemingly physiologically-matched 442 
males present significantly different eHSP70 values at rest (Figure 3). Such a large 443 
disparity in resting data will limit the ability to detect changes in eHSP70 444 
concentrations between two or more matched groups. When a repeated measures 445 
design is not feasible it may be appropriate for experimenters to match individuals 446 
based on resting eHSP70 concentrations rather than more common physiological and 447 
anthropometric features (providing that eHSP70 is an important outcome). Doing so 448 
may facilitate a clearer understanding regarding responders, such as the participant 449 
with high post HOT50 eHSP70 concentration (Figure 3, Panel B; rest = 0.67 ng.mL-1, 450 
post exercise = 2.29 ng.mL-1), and non-responders to thermal or hypoxic stress.  451 
 452 
The reasons for the observed disparity between similarly matched groups is unclear 453 
and could not be determined in the present work. In order to elucidate the role this 454 
biochemical marker plays in health and disease future studies should aim to 455 
thoroughly characterize an individual’s lifestyle factors, normal weekly physical 456 
activity levels, and anthropometric and physiological characteristics. The increased 457 
sensitivity of the ENZ-KIT compared to other commercially available kits allow for a 458 
sensitive quantification of resting eHSP70 across a wide range of populations. Only 459 
once these data have been collected in a sufficiently large sample can eHSP70 be 460 
investigated as a potential biomarker of, for example, sarcopenia (Ogawa et al. 2012). 461 
Some studies have attempted to determine the efficacy of eHSP70 in clinical 462 
scenarios using the EKS-715 assay. Based on the present work, it is likely that prior 463 
results have been influenced by sensitivity. For example Ogawa et al. (2012) 464 
conducted a detailed study in which 652 elderly Japanese males and females were 465 
screened for a range of biochemical and physiological markers related to sarcopenia, 466 
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such as TNF-α, interleukin-6 (IL-6) and C-reactive protein (CRP). However the 467 
majority of the eHSP70 data reported (436/652) was near to (n = 207; 0.13 – 0.22 468 
ng.mL-1), or below (n = 229 <0.13 ng.mL-1) the EKS-715 assay standard curve (0.20 469 
ng.mL-1). Thus, although these results are important, the present work highlights that 470 
the data should be interpreted with caution. The data in the present investigation has 471 
demonstrated that, even where eHSP70 values are theoretically within the measurable 472 
range of the EKS-715 assay (e.g. concentrations of over 0.20 ng.mL-1), they are not 473 
always detectable by EKS-715, but were all detected with ENZ-KIT (Figure 2).  474 
Thus, when resting eHSP70 concentrations are required for clinical observations or 475 
for studying the role of eHSP70 in health and disease, the use of the ENZ-KIT is 476 
recommended above EKS-715.   477 
 478 
Exercise is known to increase concentrations of eHSP70 in an intensity and duration 479 
dependent manner, with a 60 minute run at 75% V̇O2max  leading to a 175% increase 480 
in eHSP70, compared to a 140% increase when running for 120 minutes at 60% 481 
V̇O2max  (Fehrenbach et al. 2005). The sum exercise stress of cycling is less that of 482 
running due to its low impact and less muscle-damaging nature, thus cycling induced 483 
elevations in eHSP70 concentration are much lower than those observed following 484 
running (Febbraio et al. 2002; Febbraio et al. 2004; Lancaster et al. 2004). Post 485 
exercise increases in eHSP70 have been hypothesized to relate to a minimum 486 
endogenous level of thermal strain, corresponding to a Trectal of > 38.5°C (Amorim et 487 
al. 2008; Gibson et al. 2014). Both the rate of Trectal increase, and change in Trectal are 488 
also thought to be important factors affecting eHSP70 concentrations after a stressor 489 
(Periard et al. 2012; Gibson et al. 2014).  490 
 491 
In addition to the ability of the ENZ-KIT to quantify resting eHSP70, we therefore 492 
examined the post-exercise response at 3 levels of physiological strain using two 493 
distinctly different modes (running and cycling) of hyperthermic exercise, as well as 494 
hypoxic stress (Table 1). The data presented in Table 1 indicate two levels of 495 
physiological strain were achieved, with HOT70 eliciting significantly greater mean 496 
and peak HR, Trectal and PSI compared to HOT50 and HYP50. No significant 497 
differences between the HOT50 and HYP50 groups were observed, agreeing with 498 
previous work showing exercise at 50%V̇O2max in either 40°C heat or an FIO2 of 0.14 499 
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to be of a comparable physiological stress up to 40 minutes of exercise (Lee et al. 500 
2014). The 60 minute duration of exercise used herein was therefore insufficient for 501 
significant differences in physiological strain between HOT50 and HYP50 to become 502 
apparent (Girard and Racinais, 2014; Lee et al. 2014).  503 
 504 
As with the resting data, the EKS-715 kit only detected eHSP70 in the 6 samples that 505 
also provided resting data (n = 5 from HYP50, and n = 1 from HOT50).  In contrast a 506 
52% increase (Pre, 2.79 ± 2.58; Post, 3.51 ± 2.90 ng.mL-1) in eHSP70 was observed 507 
immediately after HOT70 when samples were analyzed with ENZ-KIT. This is 508 
comparable with other studies using a similar level of external heat stress at a lower 509 
exercise intensities (e.g. Periard et al. 2012) but for a longer duration (90 minutes, 510 
Gibson et al. 2014), and further illustrates the utility of the ENZ-KIT over EKS-715.  511 
 512 
The higher post exercise eHSP70 concentrations reported in the present investigation 513 
were observed despite the shorter duration of exposure (54.0 ± 9.3 minutes compared 514 
to 90.0 ± 0.0 minutes in Gibson et al. 2014) and are likely due to the increased 515 
exercise intensity (70% vs 50% V̇O2max in Gibson et al. 2014), and different exercise 516 
mode (running Vs. cycling) used between investigations. Additionally, 517 
thermoregulatory stress, evidenced by the AUC for a Trectal of  >38.5°C (9.21 ± 518 
1.95°C.min-1), the duration spent above 38.5°C (17.5 ± 10.4 minutes) and duration 519 
spent above 39°C (8.9 ± 1.6 minutes), mean and peak Trectal, change in Trectal and rate 520 
of change in HOT70 were all higher than those reported after cycling exercise at 50% 521 
V̇O2max  for 90 minutes at 30.2°C, 51% RH (Gibson et al. 2014). Thus the total level 522 
of endogenous strain was greater in the present investigation, and is reflected in the 523 
eHSP70 results.  524 
 525 
In contrast, no post exercise increase was observed following HOT50 or HYP50 526 
(Figure 3). It is likely that while the thermal component of HOT50 was sufficient for 527 
increased eHSP70, the duration of exercise, and therefore overall level of exogenous 528 
strain, was not sufficient to increase eHSP70. Of the suggested endogenous 529 
requirement for post exercise increases in eHSP70 (peak Trectal of >39.2°C, a mean 530 
Trectal of 38.6°C for a period of ~57 minutes, a core temperature change of 2.2°C from 531 
baseline at a rate of 1.6°C h-1 and a mean heart rate of 153 bt.min-1), the HOT50 trial 532 
only achieved the required heart rate, and the HYP50 group failed to reach any of 533 
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these potential eHSP70 inducing thresholds. Our data therefore lend support to the 534 
notion of a minimum endogenous criteria required for eHSP70 induction (Amorim et 535 
al. 2008; Gibson et al. 2014). The increased sensitivity afforded by the ENZ-KIT may 536 
allow for a more detailed and nuanced description of minimum eHSP70 inducing 537 
criteria during and after exercise stress in future studies.  538 
 539 
In summary, this investigation presents preliminary data showing the effectiveness of 540 
the ENZ-KIT assay for detecting and quantifying resting eHSP70 at the low end of 541 
the measurable range in young healthy males. Secondly, our results support the notion 542 
that a minimum endogenous strain threshold needs surpassing in order to increase 543 
systemic HSP70. As a result, it is recommended that all future investigations 544 
requiring accurate resting eHSP70 quantification use the ENZ-KIT assay in place of 545 
EKS-715. The increased sensitivity afforded by this assay could provide a more in 546 
depth understanding of normal and abnormal levels of systemic eHSP70, and provide 547 
novel information regarding the use of eHSP70 as a biomarker of disease.  548 
 549 
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Table 1. Mean and peak physiological and thermoregulatory responses to each trial. 
Data are mean ± SD.  
 
Total n = 21, HOT70 n = 6, HOT50 n = 7; HYP50 n = 8. 
AUC = Area under the curve. PSI = Physiological strain index.  
*** denotes significantly different from HOT50 and HYP50 (p < 0.001) 
#  denotes significantly different from HYP50 group (p < 0.05)                                                                                                                                                   
*  denotes significantly different from HOT50 (p < 0.05) 
 
 
 
 
 
 
 
 
 
 
 
 Experimental group ANOVA 
Variable HOT70 HOT50 HYP50  Trial Main effect  
Exercise duration (mins) 54.0 ± 9.4*** 60.0 ± 0.0 60.0 ± 0.0 F = 4.25, p = 0.032 
Mean HR (beats.min-1) 180 ± 8*** 153 ± 12 149 ± 13 F = 14.17, p < 0.0001 
Peak HR (beats.min-1) 190  ± 7*** 165 ± 10 157 ± 15 F = 14.61, p < 0.0001 
Mean Trectal (°C) 38.4 ± 0.3# 38.0 ± 0.2 37.9 ± 0.4 F = 4.41, p = 0.028 
Peak Trectal (°C) 39.3 ± 0.4*# 38.7 ± 0.3# 38.2 ± 0.4 F = 15.62, p < 0.0001 
Mean PSI (AU) 7.2 ± 0.6* 5.2 ± 1.0 4.8 ± 1.1 F = 11.81, p = 0.001 
Peak PSI (AU) 9.2 ± 0.8* 7.4 ± 1.2 5.9 ± 1.4 F = 13.74, p < 0.0001 
Delta change in Trectal  +2.5 ± 0.3*** +1.4 ± 0.4# +0.8 ± 0.4 F = 34.34, p < 0.0001 
Rate of Trectal change (°C h -1) 2.9 ± 0.7*** 1.4 ± 0.4# 0.8 ± 0.4 F = 31.79, p < 0.0001 
AUC for Trectal 38.5°C (°C min-1) 7.7 ± 4.1*** 1.3 ± 2.9 1.0 ± 2.7 F = 8.95, p = 0.002 
AUC for Trectal 39.0°C (°C min-1)  1.2 ± 0.9*# 0.0 ± 0.0 0.0 ± 0.0 F = 11.46, p = 0.001 
Duration above 38.5°C (mins) 17.3 ± 9.7*# 5.3 ± 7.5 3.1 ± 8.8 F = 5.06, p = 0.018 
Duration above 39.0°C (mins) 7.4 ± 3.9*** 1.4 ± 3.8 0.0 ± 0.0 F = 11.29, p = 0.001 
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Figure Legends 
 
Figure 1. Standard curves (mean ± SD; n = 4) generated in duplicate from the same 
pre-prepared standards analyzed on the same 96 well plate The amplification steps 
produce a clear increase in the assays sensitivity when compared to the EKS-715 kit 
reagents allowing for determination of low levels of eHSP70 in plasma samples. 
 
Figure 2. Panel A and B display the optical density and eHSP70 values obtained from 
each assay. EKS-715 was able to detect eHSP70 in 6 of the 32 resting observations 
(3.57 ± 2.68 ng.mL-1), whereas ENZ-KIT measured eHSP70 in all 32 resting 
observations (1.54 ± 3.19 ng.mL-1). When data for an individual was available from 
both assays (n = 12, Panel C and D) the ENZ-KIT tended to indicate lower values, 
though this was not statistically significant (p = 0.501; R2 = 0.73). Between test 
reliability for samples assayed on two different occasions was high (Panel E), with the 
between test CV 7.86% and a correlation coefficient of 0.99 (Panel F).  
 
Figure 3. eHSP70 was detected at all-time points in each trial using the ENZ-KIT, 
and was only elevated post exercise in HOT70 (Panel A, n = 6), with no post exercise 
change in eHSP70 expression observed after HOT50 (Panel B, n = 7) and HYP50 
(Panel C, n = 8). Individual data are shown with bars representing mean eHSP70.  
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